RadNet Overview
- Year Founded
-
1980
- Status
-
Public
- Employees
-
11,021
- Stock Symbol
-
RDNT
- Investments
-
94
- Share Price
-
$49.78
- (As of Thursday Closing)
RadNet General Information
Description
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Contact Information
Website
www.radnet.comCorporate Office
- 1510 Cotner Avenue
- Los Angeles, CA 90025
- United States
Corporate Office
- 1510 Cotner Avenue
- Los Angeles, CA 90025
- United States
RadNet Timeline
RadNet Stock Performance
As of 17-Apr-2025, RadNet’s stock price is $49.78. Its current market cap is $3.69B with 74M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $49.78 | $50.52 | $45.00 - $93.65 | $3.69B | 74M | 935K | $0.04 |
RadNet Financials Summary
As of 31-Dec-2024, RadNet has a trailing 12-month revenue of $1.83B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 6,382,267 | 6,382,267 | 3,733,779 | 2,568,922 |
| Revenue | 1,829,664 | 1,829,664 | 1,616,630 | 1,430,061 |
| EBITDA | 323,101 | 323,101 | 292,786 | 278,534 |
| Net Income | 2,793 | 2,793 | 3,044 | 10,650 |
| Total Assets | 3,286,690 | 3,286,690 | 2,690,473 | 2,433,907 |
| Total Debt | 1,728,863 | 1,728,863 | 1,491,120 | 1,513,468 |
RadNet Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RadNet Comparisons
Industry
Financing
Details
RadNet Competitors (11)
One of RadNet’s 11 competitors is Rayus Radiology, a Private Equity-Backed company based in St. Louis Park, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rayus Radiology | Private Equity-Backed | St. Louis Park, MN | ||||
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| SourceBio International | Formerly PE-Backed | Nottingham, United Kingdom | ||||
| Quest Diagnostics | Corporation | Secaucus, NJ | ||||
| PerkinElmer | Private Equity-Backed | Shelton, CT |
RadNet Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RadNet Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RadNet Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
RadNet Investments & Acquisitions (94)
RadNet’s most recent deal was a Merger/Acquisition with iCAD for . The deal was made on 15-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| iCAD | 15-Apr-2025 | Merger/Acquisition | Diagnostic Equipment | ||
| Stanislaus Surgical Hospital | 16-Sep-2024 | Merger/Acquisition | Buildings and Property | ||
| RadNet (Six Imaging Center Assets in Houston, Texas) | 01-Jun-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Houston Medical Imaging (7 Imaging Centers Located in Houston, Texas) | 01-Apr-2024 | Corporate Asset Purchase | Buildings and Property | ||
| Grossman Imaging Centers | 31-Mar-2024 | Merger/Acquisition | Clinics/Outpatient Services |
RadNet ESG
Risk Overview
Risk Rating
Updated January, 18, 2025
32.61 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Healthcare
Industry
of 587
Rank
Percentile
Medical Services
Subindustry
of 102
Rank
Percentile
RadNet Exits (1)
RadNet’s most recent exit was on 01-Jan-1994 from Tower Imaging. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Tower Imaging | 01-Jan-1994 | Completed |
|
RadNet Affiliates
Subsidiaries (20)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Heart & Lung Health | London, United Kingdom | 2020 | |
| Aidence | Rotterdam, Netherlands | 2015 | |
| DeepHealth (Healthcare Technology Systems) | Somerville, MA | 2015 | |
| Healthcare Radiology & Diagnostic Systems | New York, NY | 2009 | |
| RadSite | Annapolis, MD | 2005 |
RadNet FAQs
-
When was RadNet founded?
RadNet was founded in 1980.
-
Where is RadNet headquartered?
RadNet is headquartered in Los Angeles, CA.
-
What is the size of RadNet?
RadNet has 11,021 total employees.
-
What industry is RadNet in?
RadNet’s primary industry is Clinics/Outpatient Services.
-
Is RadNet a private or public company?
RadNet is a Public company.
-
What is RadNet’s stock symbol?
The ticker symbol for RadNet is RDNT.
-
What is the current stock price of RadNet?
As of 17-Apr-2025 the stock price of RadNet is $49.78.
-
What is the current market cap of RadNet?
The current market capitalization of RadNet is $3.69B.
-
What is RadNet’s current revenue?
The trailing twelve month revenue for RadNet is $1.83B.
-
Who are RadNet’s competitors?
Rayus Radiology, ARUP Laboratories, SourceBio International, Quest Diagnostics, and PerkinElmer are some of the 11 competitors of RadNet.
-
What is RadNet’s annual earnings per share (EPS)?
RadNet’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
